Belongs to

• Center for Hematologic Malignancies

Types of Work

["2019"]

[[["Journal Articles",979],["Meeting Abstracts",840],["Book Sections",26],["Conference Papers",3]]]

[1848]

Popular keywords

• adult
• aged
• article
• controlled study
• human
• human cell
• humans
• nonhuman
• priority journal
• unclassified drug

Recent Works

1. A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease

   Journal Article

   Litzow, M. R.; Wang, X. V.; Carroll, M. P.; Karp, J. E.; Ketterling, R. P.; Zhang, Y.; Kaufmann, S. H.; Lazarus, H. M.; Luger, S. M.; Paietta, E. M.; more...
   American Journal of Hematology (2019)

   Fulltext@MSK | Save
2. Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic-phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY

   Journal Article

   Hehlmann, R.; Cortes, J. E.; Zyczynski, T.; Gambacorti-Passerini, C.; Goldberg, S. L.; Mauro, M. J.; Michallet, M.; Simonsson, B.; Williams, L. A.; Gajavelli, S.; more...
   American Journal of Hematology (2019)

   Fulltext@MSK | Save
3. AGILE: A phase 3, multicenter, randomized, placebo-controlled study of ivosidenib in combination with azacitidine in adult patients with previously untreated acute myeloid leukemia with an IDH1 mutation

   Meeting Abstract

   Stein, E.; Dinardo, C. D.; Jang, J. H.; Miyazaki, Y.; Martinez, R. O.; Auer, J.; Zhang, V.; Koralek, D. O.; Wu, B.
   Journal of Clinical Oncology (2018)

   Fulltext@MSK | Save